Salvia BioElectronics

Salvia BioElectronics is a medical device company that develops neuromodulation therapies for migraines
2017
50
North Brabant, The Netherlands

Innovation

Industry Problem

Neurological diseases are hard to treat

R&D Focus

Neuromodulation therapies for migraines

Innovative Solution

Salvia has developed a paper-thin implant that delivers gentle electrical pulses to specific nerves to reduce the frequency and intensity of migraine attacks

Solution Effectiveness

Salvia implant is a flexible bioelectronic foil placed just under the skin near the nerves associated with migraine. By sending these electrical pulses through the foil, the implant aims to calm the nerves effectively and prevent and relieve migraine symptoms

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

$34.4M

Last Funding Date

February 28, 2024

Startup Stage

Growth Stage

Lead Investors

MedTech Innovator, European Innovation Council Fund, Dolby Family Ventures, Inkef, Panakes Partners

People

Founders

CEO

Products

Demo Product or Complete Product?

Development

Awards and Recognitions

Media Apperance

Biopharma Apac, Silicon Canals

M&A and Collabs

Collab

The project is led by Salvia BioElectronics B.V. in partnership with the Integrated Systems Laboratory of the Swiss Federal Technical Institute (ETH) Zurich and Schmid & Partner Engineering AG